Meyer W E, Tomcufcik A S, Chan P S, Emma J E
J Med Chem. 1984 Dec;27(12):1705-10. doi: 10.1021/jm00378a030.
The synthesis of a series of N2-[4-[(arylmethyl)amino]-2, 6-dichlorophenyl]-N1,N1-dimethylformamidines that caused marked blood pressure lowering and/or diuresis in spontaneously hypertensive rats (SHR) is reported. Diuretic activity was not always associated with acute antihypertensive activity. Central nervous system effects, most notably sedation, were observed. Compound 9d, which lowered arterial blood pressure 37 mmHg in SHR when dosed at 100 mg/kg, was further evaluated in chronic hypertensive dogs because of apparent minimal CNS effects. A reduction in arterial blood pressure of 32 mmHg at 1.0 mg/kg during a 6-h postdosing interval was observed. This response was unrelated to alpha- or beta-adrenergic blockade, angiotensin I antagonism, or neuronal or ganglionic blockade. CNS effects were also observed.
报道了一系列N2-[4-[(芳基甲基)氨基]-2,6-二氯苯基]-N1,N1-二甲基甲脒的合成,这些化合物在自发性高血压大鼠(SHR)中引起显著的血压降低和/或利尿作用。利尿活性并不总是与急性抗高血压活性相关。观察到中枢神经系统效应,最显著的是镇静作用。化合物9d在100mg/kg剂量时可使SHR的动脉血压降低37mmHg,由于其对中枢神经系统的影响明显最小,因此在慢性高血压犬中进行了进一步评估。在给药后6小时的间隔内,观察到在1.0mg/kg剂量时动脉血压降低32mmHg。这种反应与α或β肾上腺素能阻断、血管紧张素I拮抗或神经元或神经节阻断无关。也观察到了中枢神经系统效应。